Evaluation of an automated auditory brainstem response in a multi-stage infant hearing screening

• DOI: 10.1007/s00405-010-1209-z
• Publication Date: 2010-02-10T06:15:38Z
• Authors: Luca Guastini; Renzo Mora; Massimo Dellepiane; Valentina Santomauro; Massimiliano Mora; Antonio Rocca; Angelo Salami
• Keywords: Auditory brainstem response; Otoacoustic emission; False positive rate; Congenital hearing loss

An automated auditory brainstem response (AABR) method, the Maico MB-11 with BERAphone, has been developed for hearing screening in newborns. The aim of this study was to test the validity of this automated ABR screening method in a multistage newborn hearing screening (NHS). We applied a "five level" protocol using transient evoked otoacoustic emission (TEOAE), AABR-MB-11 with BERAphone and conventional auditory brainstem response (ABR). TEOAE, AABR, and conventional ABR testing were performed by ENT specialists experienced in neonatal screening techniques. Among the 8,671 newborns tested (males 3,889; females 4,782), only 42 newborns were lost to follow-up and the final false-positive rate was of 0.03%. Our experience highlights that for the neonatal period, conventional auditory brainstem response is the most reliable method for assessing the hearing level and minimizing the false-positive rate. Although AABR (performed by ENT specialists experienced in neonatal screening techniques) is easy to use, fast and with a good compliance, the device is unable to provide accurate and certain diagnosis on the degree of hearing loss to allow a proper treatment.